{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:05:58Z","timestamp":1790424358465,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":885,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1111\/jth.14785","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T10:02:45Z","timestamp":1582884165000},"page":"1278-1290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Investigating the clearance of VWF A\u2010domains using site\u2010directed PEGylation and novel N\u2010linked glycosylation"],"prefix":"10.1016","volume":"18","author":[{"given":"Judicael","family":"Fazavana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Chion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Terraube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuenlei","family":"Parng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-8739","authenticated-orcid":false,"given":"Jamie M.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1111\/jth.14785_bb0010","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1111\/jth.14785_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"issue":"21","key":"10.1111\/jth.14785_bb0020","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"issue":"14","key":"10.1111\/jth.14785_bb0025","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"Lavin","year":"2018","journal-title":"Blood Adv"},{"issue":"6","key":"10.1111\/jth.14785_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","article-title":"Elevated factor VIII levels and risk of venous thrombosis","volume":"157","author":"Jenkins","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1111\/jth.14785_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jth.14343","article-title":"High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor","volume":"17","author":"Rietveld","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1111\/jth.14785_bb0040","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/jth.12008","article-title":"von Willebrand factor: the old, the new and the unknown","volume":"10","author":"Lenting","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"02","key":"10.1111\/jth.14785_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0037-1607352","article-title":"Emerging roles for von Willebrand factor in cancer cell biology","volume":"44","author":"O'Sullivan","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1111\/jth.14785_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance \u2010 biological mechanisms and clinical significance","volume":"183","author":"O'Sullivan","year":"2018","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1111\/jth.14785_bb0055","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood-2008-01-133181","article-title":"Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo","volume":"112","author":"van Schooten","year":"2008","journal-title":"Blood"},{"issue":"13","key":"10.1111\/jth.14785_bb0060","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1111\/jth.14785_bb0065","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jth.12875","article-title":"von Willebrand factor arginine 1205 substitution results in accelerated macrophage\u2010dependent clearance in vivo","volume":"13","author":"Rawley","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"15","key":"10.1111\/jth.14785_bb0070","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood-2016-04-709436","article-title":"N\u2010linked glycans within the A2 domain of von Willebrand factor modulate macrophage\u2010mediated clearance","volume":"128","author":"Chion","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1111\/jth.14785_bb0075","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","article-title":"Macrophage LRP1 contributes to the clearance of von Willebrand factor","volume":"119","author":"Rastegarlari","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1111\/jth.14785_bb0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3324\/haematol.2017.175216","article-title":"Macrophage scavenger receptor SR\u2010AI contributes to the clearance of von Willebrand factor","volume":"103","author":"Wohner","year":"2018","journal-title":"Haematologica"},{"issue":"8","key":"10.1111\/jth.14785_bb0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2017-06-787853","article-title":"A novel role for the macrophage galactose\u2010type lectin (MGL) receptor in mediating von Willebrand factor clearance","volume":"131","author":"Ward","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1111\/jth.14785_bb0090","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/jth.13537","article-title":"N\u2010linked glycan truncation causes enhanced clearance of plasma\u2010derived von Willebrand factor","volume":"14","author":"O'Sullivan","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"15","key":"10.1111\/jth.14785_bb0095","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood-2016-04-709436","article-title":"N\u2010linked glycan sites within the A2 domain of von Willebrand factor modulate macrophage\u2010mediated clearance","volume":"128","author":"Chion","year":"2016","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1111\/jth.14785_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/jth.12226","article-title":"Clearance of von Willebrand factor","volume":"11","author":"Casari","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"17","key":"10.1111\/jth.14785_bb0105","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1074\/jbc.273.17.10396","article-title":"Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib","volume":"273","author":"Emsley","year":"1998","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1111\/jth.14785_bb0110","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.0903679106","article-title":"Structural specializations of A2, a force\u2010sensing domain in the ultralarge vascular protein von Willebrand factor","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14785_bb0115","doi-asserted-by":"crossref","first-page":"25162","DOI":"10.1074\/jbc.272.40.25162","article-title":"The von willebrand factor A3 domain does not contain a metal ion\u2010dependent adhesion site motif","volume":"272","author":"Bienkowska","year":"1997","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1111\/jth.14785_bb0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2009-11-254755","article-title":"Rational design of a fully active, long\u2010acting PEGylated factor VIII for hemophilia A treatment","volume":"116","author":"Mei","year":"2010","journal-title":"Blood"},{"issue":"19","key":"10.1111\/jth.14785_bb0125","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2012-10-415000","article-title":"Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities","volume":"121","author":"Preston","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14785_bb0130","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3324\/haematol.2009.019927","article-title":"Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia","volume":"95","author":"Casonato","year":"2010","journal-title":"Haematologica"},{"issue":"6","key":"10.1111\/jth.14785_bb0135","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2006-06-032706","article-title":"Variations in glycosylation of von Willebrand factor with O\u2010linked sialylated T antigen are associated with its plasma levels","volume":"109","author":"van Schooten","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1111\/jth.14785_bb0140","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM\u20101VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1111\/jth.14785_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1538-7836.2007.02809.x","article-title":"von Willebrand factor: evidence for variable clearance in vivo according to Y\/C1584 phenotype and ABO blood group","volume":"6","author":"Davies","year":"2007","journal-title":"J Thromb Haemost JTH"},{"issue":"23","key":"10.1111\/jth.14785_bb0150","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1182\/blood-2009-12-257949","article-title":"The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function","volume":"115","author":"Luken","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1111\/jth.14785_bb0155","article-title":"Biochemical and functional characterization of PEGylated rVWF","volume":"108","author":"Turecek","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1111\/jth.14785_bb0160","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"issue":"25","key":"10.1111\/jth.14785_bb0165","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1182\/blood-2013-04-496851","article-title":"Altered glycosylation of platelet\u2010derived von Willebrand factor confers resistance to ADAMTS13 proteolysis","volume":"122","author":"McGrath","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14785","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14785","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14785","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622014209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622014209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:27:08Z","timestamp":1761535628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622014209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1538783622014209"],"URL":"https:\/\/doi.org\/10.1111\/jth.14785","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the clearance of VWF A\u2010domains using site\u2010directed PEGylation and novel N\u2010linked glycosylation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}